A Role for Oxytocin in the Etiology and Treatment of Schizophrenia

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2015 Jun 20

PMID 26089815

Citations 17

Authors

Megan Elizabeth Rich

Heather Kingsley Caldwell

Affiliations

Soon will be listed here.

Abstract

Schizophrenia is a chronic debilitating neuropsychiatric disorder estimated to affect 51 million people worldwide. Several symptom domains characterize schizophrenia, including negative symptoms, such as social withdrawal and anhedonia, cognitive impairments, such as disorganized thinking and impaired memory, and positive symptoms, such as hallucinations and delusions. While schizophrenia is a complex neuropsychiatric disorder with no single "cause," there is evidence that the oxytocin (Oxt) system may be dysregulated in some individuals. Further, treatment with intranasal Oxt reduces some of the heterogeneous symptoms associated with schizophrenia. Since Oxt is known for its modulatory effects on a variety of social and non-social behaviors, it is perhaps not surprising that it may contribute to some aspects of schizophrenia and could also be a useful therapeutic agent. In this review, we highlight what is known about Oxt's contributions to schizophrenia and schizophrenia-related behaviors and discuss its potential as a therapeutic agent.

Citing Articles

Linking childhood trauma to the psychopathology of schizophrenia: the role of oxytocin.

Chen Y, Lu M, Chiu Y, Chen C, Santos V, Goh K Schizophrenia (Heidelb). 2024; 10(1):24.

PMID: 38388569 PMC: 10883944. DOI: 10.1038/s41537-024-00433-9.

Intranasal Peptide Therapeutics: A Promising Avenue for Overcoming the Challenges of Traditional CNS Drug Development.

Bose M, Farias Quipildor G, Ehrlich M, Salton S Cells. 2022; 11(22).

PMID: 36429060 PMC: 9688574. DOI: 10.3390/cells11223629.

Differential H3K9me2 heterochromatin levels and concordant mRNA expression in postmortem brain tissue of individuals with schizophrenia, bipolar, and controls.

Rizavi H, Chase K, Liu C, Gavin H, Rosen C, Xia C Front Psychiatry. 2022; 13:1006109.

PMID: 36386965 PMC: 9644155. DOI: 10.3389/fpsyt.2022.1006109.

Treatments for Social Interaction Impairment in Animal Models of Schizophrenia: A Critical Review and Meta-analysis.

Hazani R, Lavidor M, Weller A Schizophr Bull. 2022; 48(6):1179-1193.

PMID: 35925025 PMC: 9673263. DOI: 10.1093/schbul/sbac093.

Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction.

Goh K, Chen C, Wu T, Chen C, Lu M Int J Mol Sci. 2022; 23(13).

PMID: 35806096 PMC: 9266532. DOI: 10.3390/ijms23137092.

References

Arendt T, Bigl V, ARENDT A, TENNSTEDT A . Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease. Acta Neuropathol. 1983; 61(2):101-8. DOI: 10.1007/BF00697388. View

Lagan M, Knights K, Barton J, Boyce P . Advocacy for mothers with psychiatric illness: a clinical perspective. Int J Ment Health Nurs. 2009; 18(1):53-61. DOI: 10.1111/j.1447-0349.2008.00576.x. View

Braga R, Reynolds G, Siris S . Anxiety comorbidity in schizophrenia. Psychiatry Res. 2013; 210(1):1-7. DOI: 10.1016/j.psychres.2013.07.030. View

Montag C, Brockmann E, Bayerl M, Rujescu D, Muller D, Gallinat J . Oxytocin and oxytocin receptor gene polymorphisms and risk for schizophrenia: a case-control study. World J Biol Psychiatry. 2012; 14(7):500-8. DOI: 10.3109/15622975.2012.677547. View

Nishimori K, Takayanagi Y, Yoshida M, Kasahara Y, Young L, Kawamata M . New aspects of oxytocin receptor function revealed by knockout mice: sociosexual behaviour and control of energy balance. Prog Brain Res. 2008; 170:79-90. DOI: 10.1016/S0079-6123(08)00408-1. View

Fone K, Porkess M . Behavioural and neurochemical effects of post-weaning social isolation in rodents-relevance to developmental neuropsychiatric disorders. Neurosci Biobehav Rev. 2008; 32(6):1087-102. DOI: 10.1016/j.neubiorev.2008.03.003. View

Tsuda M, Yamaguchi N, Ogawa S . Early life stress disrupts peripubertal development of aggression in male mice. Neuroreport. 2011; 22(6):259-63. DOI: 10.1097/WNR.0b013e328344495a. View

Davis M, Lee J, Horan W, Clarke A, McGee M, Green M . Effects of single dose intranasal oxytocin on social cognition in schizophrenia. Schizophr Res. 2013; 147(2-3):393-7. DOI: 10.1016/j.schres.2013.04.023. View

Davidson M, Reichenberg A, Rabinowitz J, Weiser M, Kaplan Z, Mark M . Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry. 1999; 156(9):1328-35. DOI: 10.1176/ajp.156.9.1328. View

10.

Nestler E, Hyman S . Animal models of neuropsychiatric disorders. Nat Neurosci. 2010; 13(10):1161-9. PMC: 3750731. DOI: 10.1038/nn.2647. View

11.

Tseng K, Chambers R, Lipska B . The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia. Behav Brain Res. 2008; 204(2):295-305. PMC: 2735579. DOI: 10.1016/j.bbr.2008.11.039. View

12.

Mueser K, McGurk S . Schizophrenia. Lancet. 2004; 363(9426):2063-72. DOI: 10.1016/S0140-6736(04)16458-1. View

13.

SCHOTTE A, Janssen P, Gommeren W, Luyten W, Van Gompel P, Lesage A . Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl). 1996; 124(1-2):57-73. DOI: 10.1007/BF02245606. View

14.

Osako Y, Otsuka T, Taniguchi M, Oka T, Kaba H . Oxytocin enhances presynaptic and postsynaptic glutamatergic transmission between rat olfactory bulb neurones in culture. Neurosci Lett. 2001; 299(1-2):65-8. DOI: 10.1016/s0304-3940(00)01779-1. View

15.

Nelson R, Trainor B . Neural mechanisms of aggression. Nat Rev Neurosci. 2007; 8(7):536-46. DOI: 10.1038/nrn2174. View

16.

Strauss G, Keller W, Koenig J, Gold J, Ossenfort K, Buchanan R . Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia. Schizophr Res. 2015; 162(1-3):57-61. PMC: 4339311. DOI: 10.1016/j.schres.2014.12.023. View

17.

Knobloch H, Charlet A, Hoffmann L, Eliava M, Khrulev S, Cetin A . Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron. 2012; 73(3):553-66. DOI: 10.1016/j.neuron.2011.11.030. View

18.

Dal Monte O, Noble P, Turchi J, Cummins A, Averbeck B . CSF and blood oxytocin concentration changes following intranasal delivery in macaque. PLoS One. 2014; 9(8):e103677. PMC: 4136720. DOI: 10.1371/journal.pone.0103677. View

19.

McEwen B . Brain-fluid barriers: relevance for theoretical controversies regarding vasopressin and oxytocin memory research. Adv Pharmacol. 2004; 50:531-92, 655-708. DOI: 10.1016/S1054-3589(04)50014-5. View

20.

Francis D, Champagne F, Meaney M . Variations in maternal behaviour are associated with differences in oxytocin receptor levels in the rat. J Neuroendocrinol. 2000; 12(12):1145-8. DOI: 10.1046/j.1365-2826.2000.00599.x. View